222 related articles for article (PubMed ID: 19182422)
1. Effectiveness of meropenem for the treatment of aspiration pneumonia in elderly patients.
Tokuyasu H; Harada T; Watanabe E; Okazaki R; Touge H; Kawasaki Y; Shimizu E
Intern Med; 2009; 48(3):129-35. PubMed ID: 19182422
[TBL] [Abstract][Full Text] [Related]
2. The role of anaerobes in patients with ventilator-associated pneumonia and aspiration pneumonia: a prospective study.
Marik PE; Careau P
Chest; 1999 Jan; 115(1):178-83. PubMed ID: 9925081
[TBL] [Abstract][Full Text] [Related]
3. Prospective randomized comparison study of piperacillin/tazobactam and meropenem for healthcare-associated pneumonia in Japan.
Yamamoto Y; Izumikawa K; Morinaga Y; Nakamura S; Kurihara S; Imamura Y; Miyazaki T; Tsukamoto M; Kakeya H; Yanagihara K; Yasuoka A; Kohno S
J Infect Chemother; 2013 Apr; 19(2):291-8. PubMed ID: 23345050
[TBL] [Abstract][Full Text] [Related]
4. Reappraisal of clindamycin IV monotherapy for treatment of mild-to-moderate aspiration pneumonia in elderly patients.
Kadowaki M; Demura Y; Mizuno S; Uesaka D; Ameshima S; Miyamori I; Ishizaki T
Chest; 2005 Apr; 127(4):1276-82. PubMed ID: 15821205
[TBL] [Abstract][Full Text] [Related]
5. Microbiology of severe aspiration pneumonia in institutionalized elderly.
El-Solh AA; Pietrantoni C; Bhat A; Aquilina AT; Okada M; Grover V; Gifford N
Am J Respir Crit Care Med; 2003 Jun; 167(12):1650-4. PubMed ID: 12689848
[TBL] [Abstract][Full Text] [Related]
6. Treatment of aspiration or tracheostomy-associated pneumonia in neurologically impaired children: effect of antimicrobials effective against anaerobic bacteria.
Brook I
Int J Pediatr Otorhinolaryngol; 1996 Apr; 35(2):171-7. PubMed ID: 8735413
[TBL] [Abstract][Full Text] [Related]
7. Bacteriological testing and recurrence prevention efforts in the diagnosis and treatment of nursing- and healthcare-associated pneumonia and aspiration pneumonia: A questionnaire survey of hospitals across Japan.
Kenzaka T; Kumabe A; Kosami K; Matsuoka Y; Minami K; Ninomiya D; Noda A; Yahata S
Respir Investig; 2018 Mar; 56(2):150-157. PubMed ID: 29548653
[TBL] [Abstract][Full Text] [Related]
8. Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli.
Lorente L; Lorenzo L; Martín MM; Jiménez A; Mora ML
Ann Pharmacother; 2006 Feb; 40(2):219-23. PubMed ID: 16449546
[TBL] [Abstract][Full Text] [Related]
9. Carbapenems in the treatment of severe community-acquired pneumonia in hospitalized elderly patients: a comparative study against standard therapy.
Romanelli G; Cravarezza P; Pozzi A; Franchino L; Ravizzola G; Zulli R; Donati P; Prometti P; Grassi V
J Chemother; 2002 Dec; 14(6):609-17. PubMed ID: 12583553
[TBL] [Abstract][Full Text] [Related]
10. Cefepime vs. meropenem for moderate-to-severe pneumonia in patients at risk for aspiration: An open-label, randomized study.
Oi I; Ito I; Tanabe N; Konishi S; Hamao N; Yasutomo Y; Kadowaki S; Hirai T
J Infect Chemother; 2020 Feb; 26(2):181-187. PubMed ID: 31473111
[TBL] [Abstract][Full Text] [Related]
11. Treatment of nosocomial pneumonia: an experience with meropenem.
Santos SS; Machado FR; Kiffer CR; Barone AA
Braz J Infect Dis; 2001 Jun; 5(3):124-9. PubMed ID: 11506775
[TBL] [Abstract][Full Text] [Related]
12. Aspiration pneumonia. Recognizing and managing a potentially growing disorder.
Johnson JL; Hirsch CS
Postgrad Med; 2003 Mar; 113(3):99-102, 105-6, 111-2. PubMed ID: 12647477
[TBL] [Abstract][Full Text] [Related]
13. A prospective comparison of nursing- and healthcare-associated pneumonia (NHCAP) with community-acquired pneumonia (CAP).
Fukuyama H; Yamashiro S; Tamaki H; Kishaba T
J Infect Chemother; 2013 Aug; 19(4):719-26. PubMed ID: 23354936
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous transtracheal aspiration in the diagnosis and treatment of aspiration pneumonia in children.
Brook I
J Pediatr; 1980 Jun; 96(6):1000-4. PubMed ID: 6989969
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and therapy of aspiration pneumonia].
Ott SR; Lode H
Dtsch Med Wochenschr; 2006 Mar; 131(12):624-8. PubMed ID: 16544240
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of piperacillin/tazobactam versus biapenem in late elderly patients with nursing- and healthcare-associated pneumonia.
Karino F; Miura K; Fuchita H; Koba N; Nishikawa E; Hotta T; Okimoto T; Iwamoto S; Tsubata Y; Tada M; Hamaguchi S; Honda T; Ohe M; Sutani A; Kuraki T; Takeyama H; Isobe T
J Infect Chemother; 2013 Oct; 19(5):909-15. PubMed ID: 23645226
[TBL] [Abstract][Full Text] [Related]
17. Pneumonia: the impact of risk factors on the outcome of treatment with meropenem and ceftazidime.
Finch RG; Pemberton K; Gildon KM
J Chemother; 1998 Feb; 10(1):35-46. PubMed ID: 9531074
[TBL] [Abstract][Full Text] [Related]
18. Q: Are antibiotics indicated for the treatment of aspiration pneumonia?
Daoud E; Guzman J
Cleve Clin J Med; 2010 Sep; 77(9):573-6. PubMed ID: 20810867
[No Abstract] [Full Text] [Related]
19. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
[TBL] [Abstract][Full Text] [Related]
20. [Clinical efficacy of prolonged (4 hour) drip infusion of meropenem against severe pneumonia].
Itabashi S
Jpn J Antibiot; 2007 Jun; 60(3):161-70. PubMed ID: 17867490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
